More and more studies indicate the relevance of miRNAs in inducing certain drug resistance. Our study aimed to investigate whether microRNA-130b-3p (miR-130b) mediates the chemoresistance as well as proliferation of lung cancer (LC) cells. MTS assay and apoptosis analysis were conducted to determine cell proliferation and apoptosis, respectively. Binding sites were identified using a luciferase reporter system, whereas mRNA and protein expression of target genes was determined by RT-PCR and immunoblot, Moreover, excessive miR-130b expression promoted drug resistance and proliferation, decreased apoptosis of A549 cells. These findings suggest that miR-130b targets PTEN to mediate chemoresistance, proliferation, and apoptosis via Wnt/β-catenin pathway. 3 One of the important causes for this extremely high mortality is the drug resistance in chemotherapy procedure. 4 Therefore, in order to gain better results of lung cancer therapy, it is crucial to find effective ways to counter the drug resistance through exploring
the underlying mechanisms of chemoresistance. 5 A number of studies explored cisplatin, an efficient spectrum drug against cancer that is frequently applied in the treatment of various cancers in the place of lung, breast, bladder and brain, etc. 6, 7 Cisplatin triggers cancer cell death by cross-linking with the DNAs to suppress replication and transcription. 8 However, extended records of administrating cisplatin caused great drug fastness in those cisplatin-applied tumour cells. 9, 10 In order to keep the effectiveness of the cisplatin treatment, it is imperative for lung cancer cells to maintain a steady level of sensitivity against it.
Considering recent studies that demonstrated the correlation between cancer cells and resistance to cisplatin, we examined how miR-130b
affects the cisplatin-resistance in lung tumour cells in our research.
MicroRNAs (miRNAs) are non-coding RNA molecules with around 20 to 25 nucleotides that can lead to a downregulation of target proteins through the degradation of this mRNA or through translational inhibition, which play an important role in various malignancies. 11, 12 Abnormal miRNA expression has been observed in both physiological and pathological processes multiple human cancers like proliferation, invasion, apoptosis, and chemotherapy resistance. 12 MicroRNA130b-3p (miR-130b) targets CYLD to suppress growth of cells and induce programmed death in human gastric cancer cells. 13, 14 Moreover, miR-130b was recorded to be lifted in triple negative breast cancer tissue in comparison with adjacent healthy ones, and miR-130b mediated CCNG2 that could be closely connected with the deteriorating development of the cancer in question. 15 However, the role of miR-130b in chemoresistance lung cancer cells is still unknown.
In this study, we aimed to explore the role of miR-130b in cisplatinresistance lung cancer cells. The upregulation of miR-130b was identified in cisplatin-resistance lung cancer cells. We found that miR-130b responds to cisplatin resistance through altering the targeted PTEN level and subsequence Wnt/β-catenin pathway. The discovery of miR-130b/ PTEN being a new regulator that controls cisplatin-resistance in lung cancer offers a fresh molecular insight that might be utilized in new therapy development for cisplatin resistance in lung cancer. 
| Western-blotting assay
Western blotting was conducted with antibodies for PTEN, β-catenin, β-catenin (Ser552), β-catenin (Ser675) (Cell Signalling Technology, Beverly), and β-actin (Santa Cruz Biotechnology, Santa Cruz).
| Apoptosis analysis
Hoechst 33258 nucleic acid stain purchased from Invitrogen was used for nuclear staining for the analysis of apoptosis. 16, 17 Annexin V/ propidium iodide (PI) staining was conducted with annexin-Alexa 488 (Invitrogen) and PI. Caspase activity was evaluated via the SensoLyte Homogeneous AMC Caspase-3/7 Assay Kit (Anaspec).
| Luciferase reporter analysis
To determine the impact of miR-130b, the 3′ UTR of PTEN was mag- 
| Xenografts
The experiments related to animals were conducted under the Guide 
| Statistical analysis
The analysis was conducted with GraphPad Prism V (Graphpad Software, CA, USA), and all figures were recorded as means ± SD. A t-test was used to compare among various groups. P < 0.05 was viewed as statistically significant. Figure 5D ). Meanwhile, miR130b-induced cisplatin resistance was greatly suppressed ( Figure 5E ).
All the above indicated that miR-130b overexpression was able to activate the Wnt/β-catenin pathway through downregulating PTEN in lung cancer cells.
| Targeting miR-130b overcome cisplatin resistance in vivo
To evaluate the potential function of miR-130b on cisplatin therapy internally, A549 cells with overexpressed miR-130b were implanted in mice. The miR-130b levels in the miR-130b-stable A549 cells compared with that in the routine A549 were demonstrated in Figure 6A .
We discovered that the average size of tumours in the miR-130b group was considerably larger than the EV group even though they were administrated with the same dosage of cisplatin ( Figure 6B ). This showed the overexpression of miR-130b resistance in the anti-tumour effect of cisplatin within the body. We also examined tumour cells apoptosis in xenografts, which demonstrated that cisplatin-triggered cell apoptosis was reduced while miR-130b was overexpressed ( 
| DISCUSSION
The general cause of drug resistance in tumour cells is due to accumulation of changes in genes altered the genetic pathways, thus stimulating cancer cell evolution of phenotypes. 19, 20 There have been limited effective solutions to solve the resistance problem in cancer treatment over the years. 19, 21 Previous researches have demonstrated that PTEN is related with the drug resistance in various cancers. 22 Our study gave evidence to the mechanistic connection of miR-130b upregulation in cisplatin resistance in lung cancer.
Our findings suggest that miR-130b targets PTEN to mediate chemoresistance, proliferation, and apoptosis via Wnt/β-catenin pathway in lung cancer cells. and remains a popular problem for tumour research. 28 Recently, accumulating evidence reported the relevance of Wnt/β-catenin signal pathway in the chemoresistance of various cancers. 29 Hereby, we revealed that Wnt/β-catenin has a key influence on miR-130b mediated cisplatin resistance.
| CONCLUSIONS
Our results uncovered the unique function of miR-130b in cisplatinresistance, which was done mainly through activating Wnt/β-catenin signalling pathway of lung tumour. Although the resistance to drug is a main problem for the lung cancer therapy involved cisplatin, the method for inhibition of the miR-130b could be a novel way to improve the sensitivity of lung cancer to cisplatin.
